These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15173183)

  • 1. Insertion of foreign T cell epitopes in human tumor necrosis factor alpha with minimal effect on protein structure and biological activity.
    Nielsen FS; Sauer J; Bäcklund J; Voldborg B; Gregorius K; Mouritsen S; Bratt T
    J Biol Chem; 2004 Aug; 279(32):33593-600. PubMed ID: 15173183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies.
    Sundaram R; Lynch MP; Rawale SV; Sun Y; Kazanji M; Kaumaya PT
    J Biol Chem; 2004 Jun; 279(23):24141-51. PubMed ID: 15060075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with a peptide having both T cell and conformationally restricted B cell epitopes elicits neutralizing antisera against a snake neurotoxin.
    Léonetti M; Pillet L; Maillère B; Lamthanh H; Frachon P; Couderc J; Ménez A
    J Immunol; 1990 Dec; 145(12):4214-21. PubMed ID: 1701784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2.
    Fu ZQ; Harrison RW; Reed C; Wu J; Xue YN; Chen MJ; Weber IT
    Protein Eng; 1995 Dec; 8(12):1233-41. PubMed ID: 8869635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.
    Nguyen HN; Steede NK; Robinson JE; Landry SJ
    Vaccine; 2015 Jun; 33(25):2887-96. PubMed ID: 25944298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
    Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
    J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifying TNFalpha for therapeutic use: a perspective on the TNF receptor system.
    Hasegawa A; Takasaki W; Greene MI; Murali R
    Mini Rev Med Chem; 2001 May; 1(1):5-16. PubMed ID: 12369987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
    Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
    J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human cytotoxic T-lymphocyte epitope and its agonist epitope from the nonvariable number of tandem repeat sequence of MUC-1.
    Tsang KY; Palena C; Gulley J; Arlen P; Schlom J
    Clin Cancer Res; 2004 Mar; 10(6):2139-49. PubMed ID: 15041735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an epitope of tumor necrosis factor (TNF)-receptor type 1 (p55) recognized by a TNF-alpha-antagonist monoclonal antibody.
    Corti A; Bagnasco L; Cassani G
    Lymphokine Cytokine Res; 1994 Jun; 13(3):183-90. PubMed ID: 7524695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.
    Chen P; Melchior C; Brons NH; Schlegel N; Caen J; Kieffer N
    J Biol Chem; 2001 Oct; 276(42):38628-35. PubMed ID: 11507099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of mammary tumors with a chimeric HER-2 B-cell epitope peptide vaccine.
    Dakappagari NK; Douglas DB; Triozzi PL; Stevens VC; Kaumaya PT
    Cancer Res; 2000 Jul; 60(14):3782-9. PubMed ID: 10919651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody infliximab.
    Liang S; Dai J; Hou S; Su L; Zhang D; Guo H; Hu S; Wang H; Rao Z; Guo Y; Lou Z
    J Biol Chem; 2013 May; 288(19):13799-807. PubMed ID: 23504311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequence of the removal of evolutionary conserved disulfide bridges on the structure and function of charybdotoxin and evidence that particular cysteine spacings govern specific disulfide bond formation.
    Drakopoulou E; Vizzavona J; Neyton J; Aniort V; Bouet F; Virelizier H; Ménez A; Vita C
    Biochemistry; 1998 Feb; 37(5):1292-301. PubMed ID: 9477955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutational analysis of human tumor necrosis factor-alpha receptor binding site and structure-functional relationship.
    Zhang XM; Weber I; Chen MJ
    J Biol Chem; 1992 Nov; 267(33):24069-75. PubMed ID: 1331108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human tumor necrosis factor alpha (TNF alpha) mutants with exclusive specificity for the 55-kDa or 75-kDa TNF receptors.
    Loetscher H; Stueber D; Banner D; Mackay F; Lesslauer W
    J Biol Chem; 1993 Dec; 268(35):26350-7. PubMed ID: 8253759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.
    Wan Y; Xue X; Li M; Zhang X; Qin X; Zhang C; You Y; Wang W; Jiang C; Wu S; Liu Y; Zhu W; Ran Y; Zhang Z; Han W; Zhang Y
    Cell Immunol; 2007 Apr; 246(2):55-64. PubMed ID: 17592730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.
    Abbott WM; Snow M; Eckersley S; Renshaw J; Davies G; Norman RA; Ceuppens P; Slootstra J; Benschop JJ; Hamuro Y; Lee JE; Newham P
    Biosci Rep; 2013 Aug; 33(4):. PubMed ID: 23863106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential order of T and B cell epitopes affects immunogenicity but not antibody recognition of the B cell epitope.
    Denton G; Hudecz F; Kajtár J; Murray A; Tendler SJ; Price MR
    Pept Res; 1994; 7(5):258-64. PubMed ID: 7531518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.